Blog

Welcome to The Eve Appeal blog! We hope to use this blog to challenge the taboo and help raise awareness by blogging about gynaecological cancer and hearing from brave women who have agreed to share their own experiences.

The-Eve-Appeal-Blog-C-Woman-Feature

C The Woman

Eve's CEO, Athena Lamnisos on the health care barriers faced by women with disabilities.

Full article

Gynae cancers and their taboos: It’s killing us

Eve Appeal and women’s cancer advocate Julia Tugwell shares with us what she wants to GET LIPPY about throughout May!

Full article

Ready, Set, Lippy!

#TeamEve joined forces with the beauty industry to launch our brand-new campaign - GET LIPPY - read all about the launch here

Full article

5 pro tips to cope with a heavy flow

Eve Appeal advocate Lydia Brain shares her top tips for managing heavy period flow - an issue many women face every month

Full article

It’s a wrap: Ovarian Cancer Awareness Month 2018

Chair of the Ovarian Cancer APPG, Sharon Hodgson, reflects on another successful Ovarian Cancer Awareness Month

Full article

The-Eve-Appeal-Blog-HPV-Feature

“If you think something is wrong, go to the doctor”

In our final Cervical Cancer Prevention Week blog - Jess tells us about her scare with cervical cancer

Full article

The-Eve-Appeal-Blog-Gemma

“Everyone thinks it won’t happen to them, but it did to me”

There are man key milestones in life, but for Gemma, developing cervical cancer at 28 wasn't one she expected to encounter

Full article

The realities of HPV and cervical cancer

#TeamEve advocate Julia Tugwell shares with us vital info on HPV following her own personal experience of cervical cancer

Full article

The-Eve-Appeal-Blog-Cervical-Prevention

“Don’t dwell on past smear tests…it could be costly”

#TeamEve champion Jane shares with us her advice on the importance of attending cervical screening appointments

Full article

The-Eve-Appeal-BRCA-Genetic-Testing

Whole-population testing for breast and ovarian cancer gene mutations is cost-effective

Screening the entire population for breast and ovarian cancer gene mutations is cost-effective and could save lives

Full article